Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma-Reference-Cited by-同舟云学术

Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma

Published:2017-01-19 Issue:1 Volume:18 Page:27-34
ISSN:1574-0153
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Rucksaken Rucksak¹²³,Charoensuk Lakhanawan¹²⁴,Pinlaor Porntip⁵²,Pairojkul Chawalit⁶²,Khuntikeo Narong⁷²,Pinlaor Somchai¹²

Affiliation:

1. Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

2. Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

3. Department of Veterinary Technology, Faculty of Veterinary Technology, Kasetsart University, Bangkok, Thailand

4. Department of Clinical Pathology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok 10300, Thailand

5. Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand

6. Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

7. Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference33 articles.

1. Epidemiology of cholangiocarcinoma: An update focusing on risk factors;Shin;Cancer Sci,2010

2. Cholangiocarcinoma: lessons from Thailand;Sripa;Curr Opin Gastroenterol,2008

3. Circulating markers of biliary malignancy: opportunities in proteomics?;Bonney;Lancet Oncol,2008

4. Cholangiocarcinoma-controversies and challenges;Patel;Nat Rev Gastroenterol Hepatol,2011

5. Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand;Pattanathien;Asian Pac J Cancer Prev,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control;Clinical Microbiology Reviews;2024-03-14

2. Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration;Cancer Science;2024-03-12

3. Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia;Journal of Cancer Research and Clinical Oncology;2022-10-05

4. Orosomucoid in liver diseases;World Journal of Gastroenterology;2021-12-07

5. Transcriptome analysis of sinensetin-treated liver cancer cells guided by biological network analysis;Oncology Letters;2021-03-04